{ }
UBS has initiated coverage of Dynatrace with a Neutral rating and a price target of $58, citing the company's strong position to gain market share. However, concerns about near-term revenue growth and sales execution lead UBS to adopt a cautious stance, despite positive feedback on Dynatrace's features and a healthy observability software market.
As inflation eases and interest rates decline, investors are encouraged to focus on long-term growth stocks in technology, healthcare, and energy sectors. Six top growth stocks, including Dynatrace and Medpace, exhibit strong earnings and sales growth, positioning them for substantial returns over the next decade. Staying patient with these investments can harness the power of compounding, enhancing overall wealth.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.